{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients undergoing cardiac surgery with CPB were randomized"
      },
      "Participants": {
        "score": 1,
        "evidence": "Patients undergoing cardiac surgery with CPB"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized to receive either two preoperative subcutaneous injections of liraglutide or a matching placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "We hypothesized that liraglutide increases pancreatic insulin secretion during cardiac surgery with cardiopulmonary bypass (CPB)."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "We measured hormone concentrations before and after surgery"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients undergoing cardiac surgery with CPB were randomized"
      },
      "Blinding": {
        "score": 1,
        "evidence": "matching placebo"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Metabolic hormone concentrations were measured in 37 participants."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "HOMA-B revealed that liraglutide increased insulin secretion relative to glycemia (258 \u00b1 179 vs 116 \u00b1 180, difference (95% CI): 142 (24\u2013261), P = 0.004)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "GLOBE trial, NTR6323"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}